GET THE APP

Journal of Pharmaceutical Sciences and Drug Development

Guide for Authors

Guide for Authors

1. Introduction

Cancer poses a major challenge to development; it undermines socio-economic advances throughout the world. It is estimated that the number of patients with cancer would increase from 12.7 million in the year 2008 to 22.2 million by 2030. The Journal of Pharmaceutical Science and Drug Developement is conveniently placed in the scholarly communication milieu to help counter the menace of cancer by aiding the development of novel treatment strategies, by providing novel insights into the mechanisms underlying this complex disease.

2. Bibliographic Information

Journal Name

Journal of Pharmaceutical Science and Drug Developement

Language

English

Type of Access

Open Access

Type of Review

Peer review (Single blinded)

Publishing Type

Electronic version

Publisher

IOMC publisher

Journal Issued

Quarterly

Subject Category

Pharmacology

Online Address

https://www.iomcworld.org/pharmaceutical-sciences-drug-development/guide-for-authors.html

 

3. Aims & Scope

 Journal of Pharmaceutical Science and Drug Developement strives to publish highest quality articles pertaining to clinical research, which are freely accessible to one and all. The scope of the journal encompasses topics including drug design, drug discovery, natural products, formulation, personalized medicine, testing the efficacy of drug molecule in vitro and in vivo, pharmacokinetics, pharmacogenomics, analytical sciences, nanotechnology, therapeutic aspects, quality control, optimization by medicinal chemistry, drug pharmacodynamics, evaluation of safety and toxicity of drug molecules, regulatory science as well as computational approaches

In order to create highly impactful and original content, the European Journal of Clinical Oncology has gathered an expert Editorial Board, comprising of illustrious scientists who ensure that each manuscript is fairly, but stringently peer-reviewed. The decision on all submitted manuscripts will be taken independent of nationality, academic degree and relationship of the author with the journal. Papers will be published approximately 7 days after acceptance.

4. Types of Manuscripts

4.1. Research

Research papers are based on novel researches. A research paper is a primary source of knowledge which includes the methods and results of a new study done by the authors. The kind of study may differ (it could have been an experiment, survey, interview, etc.), but in all cases, raw data have been achieved and analyzed by the authors, and conclusions drawn from the results of that analysis. Research articles follow a particular format.
Journal of Pharmaceutical Science and Drug Developement follows this content structure for research study:

1

Title

2

All authors’ information

(for corresponding author contact details must be provided)

3

Abstract

4

Keywords

5

Introduction

6

Experimental section (Materials & methods)

7

Results and discussion

8

Conclusion

9

Acknowledgment

10

Authors’ contribution

11

Conflict of interest

12

References

 

4.2. Short communication

A brief research work considered as Short communication by Lexis publisher and Journal of Pharmaceutical Science and Drug Developement. Structure of Short communication defined similar to a research paper.

Important note: If a manuscript is submitted as an original research with brief and scant data then the editorial boards may consider the article as a Short communication.

4.3. Review

Review articles are written based mostly on secondary data that is falling in line with the theme of the journal. They are brief, yet critical discussions on a specific aspect of the subject concerned. Reviews generally start with the statement of the problem with a brief abstract of 300 words and few key words. The main objective of Reviews is to offer systematic and substantial coverage of advanced topics, evaluations of development in identified subjects, and/or critical assessments of emerging knowledge. Journal of Pharmaceutical Science and Drug Developement follows this content structure for review:

1

Title

2

All authors’ information

(for corresponding author contact details must be provided)

3

Abstract

4

Keywords

5

Introduction

6

Review elements

7

Conclusion

8

Acknowledgment

9

Authors’ contribution

10

Conflict of interest

11

References

4.4. Mini Review

The structure of a Mini Review is almost similar to that of a Review paper but generally it is concised to a word limit of 2200.

4.5. Case Report

A case report is a complete report of the symptoms, signs, diagnosis, treatment and follow-up of a specific patient. Case reports could cover a demographic outline of the patient, but generally explain an uncommon or novel occurrence. Some case reports also have a literature review of former reported cases.Journal of Pharmaceutical Science and Drug Developement follows this content structure for case report:

1

Title

2

All authors’ information

(for corresponding author contact details must be provided)

3

Abstract

4

Keywords

5

Introduction

6

Case presentation

7

Discussion

8

Conclusion

9

Acknowledgment

10

Author’s contribution

11

Conflict of interest

12

References

 

5. Article Processing Charges

IOMC Publisher is a self-financed and does not receive funding from any institution/government. Hence, the Journal operates solely through processing charges we receive from the authors and some academic/corporate sponsors.

Article Type

Article Processing Charges

USD

Euro

GBP

Regular Article

919

813

723

Special Issue article

719

636

565

The basic article processing fee or manuscript handling cost is as per the price mentioned above on the other hand it may vary based on the extensive editing, colored effects, complex equations, extra elongation of no. of pages of the article, etc.

Note: This publication charges are also applicable to invited authors.

6. Publication Ethics

For publication ethics related information please visit https://www.iomcworld.org/pharmaceutical-sciences-drug-development/guide-for-authors.html

7. Medical Ethics

7.1. Informed consent

In general, informed consent assumes that authors are legally able to make their own decisions. For informed consent to take place, the information that’s given must be understood. The informed consent process is meant to give patients ongoing explanations that will help them make informed decisions about whether to start or stay in a clinical trial. The most important part of this process is their everyday interaction and discussions with the research team and other medical staff before, during, and after the trial. The consent form can be a great tool to help get this conversation started. This is all done so that patients can make the best decision for him/her, and to be sure that they are able to choose freely whether to enroll in or stay in the study. Much of this information may be on the consent form itself, which also regularly describes that they can withdraw from the study at any time without penalty. Before, during, and even after the clinical trial, patients will have the chance to ask questions and voice their concerns. Informed consent for clinical trials goes on for as long as the research lasts, and even afterward. Also Lexispublisher and Journal of Pharmaceutical Science and Drug Developement confirmed and followed WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects.

7.2. FDA (Food and Drug Administration) approval

The Federal Food, Drug, and Cosmetic Act is the basic food and drug law of the U.S. With many revisions, it is the most extensive law of its kind in the world. The law is planned to assure the user that foods are pure and healthy, safe to eat, and produced under healthy conditions; that drugs and devices are safe and effective for their proposed uses; that cosmetics are safe and made from suitable ingredients; and that all labeling and packaging is truthful, informative, and not deceptive. The authors should only use FDA approved products for medical studies on humans.

Relevant Topics

 
Top